```

[Federal Register Volume 88, Number 196 (Thursday, October 12, 2023)]
[Notices]
[Pages 70680-70681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22584]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration

Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Commission on Childhood Vaccines 
(ACCV) will hold public meetings for the 2024 calendar year (CY). 
Information about ACCV, agendas, and materials for these meetings can 
be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

DATES: ACCV meetings will be held on March 7, 2024, 10:00 a.m.-4:00 
p.m. Eastern Time (ET); March 8, 2024, 10:00 a.m.-4:00 p.m. ET; 
September 5, 2024, 10:00 a.m.-4:00 p.m. ET; September 6, 2024, 10:00 
a.m.-4:00 p.m. ET.

ADDRESSES: Meetings may be held in-person or by Zoom webinar. For 
updates on how the meeting will be held, visit the ACCV website meeting 
page included below 30 business days before the date of the meeting, 
where instructions for joining meetings either in-person or remotely 
will be posted. In-person ACCV meetings will be held at 5600 Fishers 
Lane, Rockville, MD 20857. For meeting information updates, go to the 
ACCV website meeting page at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html.

FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, 
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-
25A, Rockville, MD 20857; 800-338-2382; or [email protected].

SUPPLEMENTARY INFORMATION: ACCV provides advice and recommendations to 
the Secretary of HHS (Secretary) on policy, program development, and 
other issues related to implementation of the National Vaccine Injury 
Compensation Program and concerning other matters as described under 
section 2119 of the Public Health Service Act (42 U.S.C. 300aa-19).
    Since priorities dictate meeting times, be advised that start 
times, end times, and agenda items are subject to change. For CY 2024 
meetings, agenda items may include, but are not limited to: updates 
from the Division of Injury Compensation Programs, Department of 
Justice, Office of Infectious Disease and HIV/AIDS Policy (HHS), 
Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health) and Center for Biologics Evaluation and 
Research (Food and Drug Administration). Refer to the ACCV website 
listed above for all current and updated information concerning the CY 
2024 ACCV meetings, including draft agendas and meeting materials that 
will be posted 5 calendar days before the meeting.
    These meetings are open to the public. Meetings held by Zoom 
webinar will require registration. Registration details will be 
provided on our ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html. All registrants will be asked to 
provide their name, affiliation, and email address. After registration, 
individuals will receive personalized Zoom information via email.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACCV should

[[Page 70681]]

be sent to Pita Gomez using the contact information listed above at 
least 5 business days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Pita Gomez using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend. Since all in-person meetings will occur in a federal 
government building, attendees must go through a security check to 
enter the building. Non-U.S. Citizen attendees must notify HRSA of 
their planned attendance at least 20 business days prior to the meeting 
to facilitate their entry into the building. All attendees are required 
to present government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-22584 Filed 10-11-23; 8:45 am]
BILLING CODE 4165-15-P
```